Fibroadenoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| Line 16: | Line 16: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
Revision as of 23:25, 26 November 2017
|
Fibroadenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma screening On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma screening |
|
Risk calculators and risk factors for Fibroadenoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for fibroadenoma.[1]
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for fibroadenoma.[1]
References
- ↑ 1.0 1.1 Fibroadenoma Recommendations. US Preventive Services Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=fibroadenoma+ Accessed on February, 1 2016